Like pharmaceutical companies globally - which used to enjoy a preferential exchange rate in Venezuela - Indian producers have been left badly stung by the collapse of the bolivar currency
The USTR has placed India on its "priority watch" list for two years in a row, saying the country's patent laws unfairly favour local drug makers.
It is one of 42 drug-making factories in India that the FDA has banned in recent years
The next hearing on Pfizer's plea is slated for March 21
A notice issued by the Indian Health Ministry at the weekend said that a government-appointed committee of experts had found that the banned combinations were "likely to involve risk to human beings, whereas safer alternatives to the said drug are available."
Dinesh Thakur is famous for exposing Ranbaxy safety problems
Credit Suisse analysts cut their rating on Sun Pharma stock to 'neutral' from 'outperform
US firm Mylan NV received a stern warning from the FDA in August for faulty manufacturing practices at three of its India drugmaking plants.
India rejects patent on Pfizer's arthritis drug
Cipla has agreed to buy two generics businesses in the United States in an all-cash deal worth $550 million.
Indian government has extended price caps to 39 more medicines ranging from commonly used diabetes drugs to antibiotics.
Reliance Industries Ltd plans to sell a 3.1 per cent stake, worth $32 million at the current market price, in unit Network18 Media & Investments.
India's $100 billion push into solar energy over the next decade will be driven by foreign players as uncompetitive local manufacturers fall by the wayside, no longer protected by government restrictions on the sector.
The push to connect India and drive a national fibre optic network, first approved by the last government in 2011, has made slow progress
All the existing microfinance businesses of the company and clients will be transferred to the bank
The shareholders will also get one redeemable preference share in Vedanta Ltd
Drugs under exemption make up roughly 95 per cent of the antiretrovirals used by India's AIDS patients
RIL has been talking to groups including Gionee, Huawei and Xiaomi
Few drugs in the market are not approved by the authorities and can be life-threatening.
Facebook Inc is launching an open platform for online content and application developers to join its Internet.org service.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances